Study on the selection of appropriate patients for the dose escalation of adalimumab in Crohn's disease therapy.
Not Applicable
Completed
- Conditions
- Crohn'disease
- Registration Number
- JPRN-UMIN000024566
- Lead Sponsor
- Toho University Medical Center Sakura Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients who correspond to the warning or contraindication of the package insert of adalimumab 2.Patients under breast-feeding 3.Patients who do not agree to join the study 4.Patients with previous use of anti-TNF therapy 5.Patients who has neoplasm 6.Patients who had intestinal resection within 6 months 7.Patients with short bowel syndrome 8.When the doctor in charge determines that the patients are not suitable for the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method